Selin Ruggieri, DPM
Foot & Ankle Surgery · Washington, DCNPI 1396301354
Payments from drug & device makers
What this record shows
16 manufacturers reported payments, led by Arthrex at 30.6% of the total.
Across 96 payments — averaging $77.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Orthofix Medical, Inc.$2K
- Supreme Orthopedic Systems, LLC$1K
- Stryker$604
- Smith+Nephew$282
- Kerecis Limited$212
- plus $703 from 10 others
What the payments were for
- Travel & lodging$4,15256%
- Food & beverage$3,32444%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $2,288 |
| Orthofix Medical, Inc. | 18 | $2,172 |
| Supreme Orthopedic Systems, LLC | 16 | $1,215 |
| Stryker | 11 | $604 |
| Smith+Nephew | 10 | $282 |
| Kerecis Limited | 2 | $212 |
| Amgen(2 entities) | 4 | $175 |
| Convatec Inc. | 3 | $170 |
| Triad Life Sciences Inc. | 1 | $112 |
| Averitas Pharma Inc. | 4 | $78 |
| Nevro Corp. | 2 | $64 |
| Solventum Corporation | 1 | $25 |
| Next Science LLC | 1 | $23 |
| Mimedx Group, Inc. | 1 | $21 |
| Sebela Pharmaceuticals Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,475 in reported general payments places this provider in the 60th percentile of 23 foot & ankle surgery providers in District of Columbia.
See all foot & ankle surgery providers in District of Columbia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 20 | $333 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Washington
- Paul CooperWashington$186K
- John SteinbergWashington$166K
- Ali Rahnama VaghefWashington$132K
- Jayson AtvesWashington$24K
- Shelton McKenzieWashington$22K
- Bilal LouzatiWashington$18K
- Ali QadriWashington$17K
- Alex MattiaWashington$13K
- Emily DurranceWashington$9K
- Caitlin ZarickWashington$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.